129 related articles for article (PubMed ID: 34103990)
1. The Functional Hallmarks of Cancer Predisposition Genes.
Capellini A; Williams M; Onel K; Huang KL
Cancer Manag Res; 2021; 13():4351-4357. PubMed ID: 34103990
[TBL] [Abstract][Full Text] [Related]
2. Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than
Robson M
J Clin Oncol; 2021 Aug; 39(23):2528-2534. PubMed ID: 34106763
[No Abstract] [Full Text] [Related]
3. RADX prevents genome instability by confining replication fork reversal to stalled forks.
Krishnamoorthy A; Jackson J; Mohamed T; Adolph M; Vindigni A; Cortez D
Mol Cell; 2021 Jul; 81(14):3007-3017.e5. PubMed ID: 34107305
[TBL] [Abstract][Full Text] [Related]
4. ASPM promotes homologous recombination-mediated DNA repair by safeguarding BRCA1 stability.
Xu S; Wu X; Wang P; Cao SL; Peng B; Xu X
iScience; 2021 Jun; 24(6):102534. PubMed ID: 34142045
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.
Stadler ZK; Maio A; Chakravarty D; Kemel Y; Sheehan M; Salo-Mullen E; Tkachuk K; Fong CJ; Nguyen B; Erakky A; Cadoo K; Liu Y; Carlo MI; Latham A; Zhang H; Kundra R; Smith S; Galle J; Aghajanian C; Abu-Rustum N; Varghese A; O'Reilly EM; Morris M; Abida W; Walsh M; Drilon A; Jayakumaran G; Zehir A; Ladanyi M; Ceyhan-Birsoy O; Solit DB; Schultz N; Berger MF; Mandelker D; Diaz LA; Offit K; Robson ME
J Clin Oncol; 2021 Aug; 39(24):2698-2709. PubMed ID: 34133209
[TBL] [Abstract][Full Text] [Related]
6. Cavin3 released from caveolae interacts with BRCA1 to regulate the cellular stress response.
McMahon KA; Stroud DA; Gambin Y; Tillu V; Bastiani M; Sierecki E; Polinkovsky ME; Hall TE; Gomez GA; Wu Y; Parat MO; Martel N; Lo HP; Khanna KK; Alexandrov K; Daly R; Yap A; Ryan MT; Parton RG
Elife; 2021 Jun; 10():. PubMed ID: 34142659
[TBL] [Abstract][Full Text] [Related]
7. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.
Bardia A; Tolaney SM; Punie K; Loirat D; Oliveira M; Kalinsky K; Zelnak A; Aftimos P; Dalenc F; Sardesai S; Hamilton E; Sharma P; Recalde S; Gil EC; Traina T; O'Shaughnessy J; Cortes J; Tsai M; Vahdat L; Diéras V; Carey LA; Rugo HS; Goldenberg DM; Hong Q; Olivo M; Itri LM; Hurvitz SA
Ann Oncol; 2021 Sep; 32(9):1148-1156. PubMed ID: 34116144
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
[TBL] [Abstract][Full Text] [Related]
9. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma.
Lawson BC; Yang RK; Euscher ED; Ramalingam P; Malpica A
Hum Pathol; 2021 Sep; 115():76-83. PubMed ID: 34153306
[TBL] [Abstract][Full Text] [Related]
10. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Diossy M; Sztupinszki Z; Borcsok J; Krzystanek M; Tisza V; Spisak S; Rusz O; Timar J; Csabai I; Fillinger J; Moldvay J; Pedersen AG; Szuts D; Szallasi Z
NPJ Precis Oncol; 2021 Jun; 5(1):55. PubMed ID: 34145376
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer.
Chappell K; Manna K; Washam CL; Graw S; Alkam D; Thompson MD; Zafar MK; Hazeslip L; Randolph C; Gies A; Bird JT; Byrd AK; Miah S; Byrum SD
Mol Omics; 2021 Oct; 17(5):677-691. PubMed ID: 34142686
[TBL] [Abstract][Full Text] [Related]
12. Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
Fountzilas E; Kotoula V; Koliou GA; Liontos M; Papadopoulou K; Giannoulatou E; Papanikolaou A; Tikas I; Chrisafi S; Mauri D; Chatzopoulos K; Fostira F; Pectasides D; Oikonomopoulos G; Aivazi D; Andrikopoulou A; Visvikis A; Aravantinos G; Zagouri F; Fountzilas G
Front Oncol; 2021; 11():683057. PubMed ID: 34141624
[TBL] [Abstract][Full Text] [Related]
13. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
[TBL] [Abstract][Full Text] [Related]
14. Recent Insights on Genetic Testing in Primary Prostate Cancer.
Kafka M; Surcel C; Heidegger I
Mol Diagn Ther; 2021 Jul; 25(4):425-438. PubMed ID: 34118026
[TBL] [Abstract][Full Text] [Related]
15. Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
Li N; Lim BWX; Thompson ER; McInerny S; Zethoven M; Cheasley D; Rowley SM; Wong-Brown MW; Devereux L; Gorringe KL; Sloan EK; Trainer A; Scott RJ; James PA; Campbell IG
NPJ Breast Cancer; 2021 Jun; 7(1):76. PubMed ID: 34117267
[TBL] [Abstract][Full Text] [Related]
16. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Lakeman IMM; van den Broek AJ; Vos JAM; Barnes DR; Adlard J; Andrulis IL; Arason A; Arnold N; Arun BK; Balmaña J; Barrowdale D; Benitez J; Borg A; Caldés T; Caligo MA; Chung WK; Claes KBM; ; ; Collée JM; Couch FJ; Daly MB; Dennis J; Dhawan M; Domchek SM; Eeles R; Engel C; Evans DG; Feliubadaló L; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Gayther SA; Gerdes AM; Godwin AK; Goldgar DE; Hahnen E; Hake CR; Hamann U; Hogervorst FBL; Hooning MJ; Hopper JL; Hulick PJ; Imyanitov EN; ; ; ; Isaacs C; Izatt L; Jakubowska A; James PA; Janavicius R; Jensen UB; Jiao Y; John EM; Joseph V; Karlan BY; Kets CM; Konstantopoulou I; Kwong A; Legrand C; Leslie G; Lesueur F; Loud JT; Lubiński J; Manoukian S; McGuffog L; Miller A; Gomes DM; Montagna M; Mouret-Fourme E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Olah E; Olopade OI; Park SK; Parsons MT; Peterlongo P; Piedmonte M; Radice P; Rantala J; Rennert G; Risch HA; Schmutzler RK; Sharma P; Simard J; Singer CF; Stadler Z; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teo SH; Teulé A; Thomassen M; Thull DL; Tischkowitz M; Toland AE; Tung N; van Rensburg EJ; Vega A; Wappenschmidt B; Devilee P; van Asperen CJ; Bernstein JL; Offit K; Easton DF; Rookus MA; Chenevix-Trench G; Antoniou AC; Robson M; Schmidt MK
Genet Med; 2021 Sep; 23(9):1726-1737. PubMed ID: 34113011
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer.
Woodward ER; van Veen EM; Forde C; Harkness EF; Byers HJ; Ellingford JM; Burghel GJ; Schlech H; Bowers NL; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ; Gareth Evans D
Genet Med; 2021 Oct; 23(10):1969-1976. PubMed ID: 34113003
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage.
Vohhodina J; Goehring LJ; Liu B; Kong Q; Botchkarev VV; Huynh M; Liu Z; Abderazzaq FO; Clark AP; Ficarro SB; Marto JA; Hatchi E; Livingston DM
Nat Commun; 2021 Jun; 12(1):3542. PubMed ID: 34112789
[TBL] [Abstract][Full Text] [Related]
19. Implications of targeted next-generation sequencing for bladder cancer: report of four cases.
Khalifa MK; Bakr NM; Ramadan A; Abd Elwahab KM; Desoky E; Nageeb AM; Swellam M
J Genet Eng Biotechnol; 2021 Jun; 19(1):91. PubMed ID: 34152511
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).
Tannous EA; Burgers PM
Crit Rev Biochem Mol Biol; 2021 Oct; 56(5):441-454. PubMed ID: 34151669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
